# 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination

> **NCT00972257** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 64 (actual)

## Conditions studied

- Glaucoma

## Interventions

- **DRUG:** treatment with dorzolamide/timolol
- **DRUG:** treatment with brimonidine/timolol

## Key facts

- **NCT ID:** NCT00972257
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2014-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00972257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00972257, "24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed Combination". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00972257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*